Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of the Dietary Supplement CardioFlex Q10 on Reducing Cardiovascular Disease Risk Factors in Adults

NCT03826914 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.

NCT NCT03826914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03826914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of the Dietary Supplement CardioFlex Q10 on Reducing Cardiovascular Disease Risk Factors in Adults
Lead sponsor
University of Manitoba
Phase
Not applicable
Overall status
Completed
Start date
November 6, 2018
Completion date
August 1, 2020
Enrollment
69 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular abnormalities, cardiovascular diseases, heart attack, hypertension, stroke